Ocean Biomedical (OCEA) Stock Price, News & Analysis

Company Overview

Ocean Biomedical, Inc. is a biotechnology company focused on discovering and developing novel therapies, vaccines and diagnostic products. Its research programs are centered on areas of significant unmet medical need, including cancer, infectious diseases, pulmonary conditions, inflammation and fibrosis.

The company uses antibody-based and other biologic approaches to identify potential treatments and has developed a portfolio of intellectual property and product candidates through collaborations with academic and research institutions. Its programs have included work targeting cancer biology, immune responses to infectious diseases and mechanisms involved in fibrotic and respiratory disorders.

Ocean Biomedical was established by a group of physician-scientists and has been associated with research activities in Providence, Rhode Island. The company became publicly traded in 2023 and has since been represented in the over-the-counter market under the symbol OCEA.

Key Stats

• Today's Range: $0.0001 to $0.0006
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0059
• Volume: 312 shs
• Average Volume: 65,373 shs
• Market Capitalization: $99.61 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Ocean Biomedical Stock Analysis - MarketRank™

Ocean Biomedical scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Ocean Biomedical.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Ocean Biomedical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ocean Biomedical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.71% of the float of Ocean Biomedical has been sold short.

Short Interest Ratio / Days to Cover

Ocean Biomedical has a short interest ratio ("days to cover") of 1.29, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ocean Biomedical does not currently pay a dividend.

Dividend Growth

Ocean Biomedical does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

3 people have searched for OCEA on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ocean Biomedical insiders have not sold or bought any company stock.

Percentage Held by Insiders

17.95% of the stock of Ocean Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

24.55% of the stock of Ocean Biomedical is held by institutions.

Company Calendar

• Last Earnings: 4/08/2025
• Today: 10/16/2026
• Next Earnings (Estimated): 12/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:OCEA
• CIK: 1836612
• Web: N/A
• Phone: 646-908-2658
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.33)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$114.47 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -931.55%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.03
• Quick Ratio: 0.03

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.62) per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 166,011,000
• Free Float: 9,240,000
• Market Cap: $99.61 thousand
• Optionable: No Data
• Beta: 1.63